BNP Paribas Financial Markets’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $80 | Hold |
44
| – | – | ﹤0.01% | 4519 |
|
2025
Q1 | $89 | Sell |
44
-101
| -70% | -$204 | ﹤0.01% | 4428 |
|
2024
Q4 | $868 | Sell |
145
-2,629
| -95% | -$15.7K | ﹤0.01% | 4249 |
|
2024
Q3 | $27.1K | Sell |
2,774
-14,297
| -84% | -$140K | ﹤0.01% | 2991 |
|
2024
Q2 | $350K | Buy |
17,071
+15,712
| +1,156% | +$322K | ﹤0.01% | 2187 |
|
2024
Q1 | $61.3K | Sell |
1,359
-105
| -7% | -$4.74K | ﹤0.01% | 2882 |
|
2023
Q4 | $69.1K | Sell |
1,464
-3,302
| -69% | -$156K | ﹤0.01% | 2781 |
|
2023
Q3 | $193K | Buy |
4,766
+391
| +9% | +$15.8K | ﹤0.01% | 2441 |
|
2023
Q2 | $466K | Sell |
4,375
-2,736
| -38% | -$292K | ﹤0.01% | 2033 |
|
2023
Q1 | $2.12M | Buy |
7,111
+4,900
| +222% | +$1.46M | ﹤0.01% | 1308 |
|
2022
Q4 | $760K | Sell |
2,211
-1,162
| -34% | -$399K | ﹤0.01% | 1723 |
|
2022
Q3 | $638K | Sell |
3,373
-562
| -14% | -$106K | ﹤0.01% | 2168 |
|
2022
Q2 | $831K | Sell |
3,935
-1,271
| -24% | -$268K | ﹤0.01% | 1756 |
|
2022
Q1 | $1.74M | Buy |
5,206
+1,029
| +25% | +$344K | ﹤0.01% | 1476 |
|
2021
Q4 | $1.36M | Buy |
4,177
+2,597
| +164% | +$845K | ﹤0.01% | 1827 |
|
2021
Q3 | $767K | Buy |
1,580
+464
| +42% | +$225K | ﹤0.01% | 1990 |
|
2021
Q2 | $519K | Buy |
1,116
+556
| +99% | +$258K | ﹤0.01% | 1953 |
|
2021
Q1 | $386K | Buy |
560
+473
| +544% | +$326K | ﹤0.01% | 2178 |
|
2020
Q4 | $64.4K | Sell |
87
-102
| -54% | -$75.6K | ﹤0.01% | 2784 |
|
2020
Q3 | $131K | Buy |
189
+50
| +36% | +$34.7K | ﹤0.01% | 2367 |
|
2020
Q2 | $118K | Buy |
139
+8
| +6% | +$6.77K | ﹤0.01% | 2091 |
|
2020
Q1 | $46.7K | Buy |
131
+75
| +134% | +$26.7K | ﹤0.01% | 2958 |
|
2019
Q4 | $13K | Buy |
56
+37
| +195% | +$8.6K | ﹤0.01% | 3428 |
|
2019
Q3 | $2.1K | Buy |
19
+18
| +1,800% | +$1.99K | ﹤0.01% | 3709 |
|
2019
Q2 | $175 | Buy |
+1
| New | +$175 | ﹤0.01% | 3834 |
|